{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:04:58Z","timestamp":1780423498050,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81330003"],"award-info":[{"award-number":["81330003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012252","name":"Fujian Province Innovation and Entrepreneurship Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yjmcc.2019.09.010","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T19:17:14Z","timestamp":1571339834000},"page":"34-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Genetic ablation and pharmacological inhibition of immunosubunit \u03b25i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice"],"prefix":"10.1016","volume":"137","author":[{"given":"Hua-Jun","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Xin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pang-bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-4016","authenticated-orcid":false,"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2019.09.010_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.09.010_bb0010","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J. Lab. Clin. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.09.010_bb0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/157340310793566109","article-title":"The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress","volume":"6","author":"Iyer","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.09.010_bb0020","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/HYPERTENSIONAHA.110.165829","article-title":"Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice","volume":"57","author":"Grobe","year":"2011","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.yjmcc.2019.09.010_bb0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000489757","article-title":"Cardiac ablation of SOCS3 aggravates DOCA-salt-induced hypertrophic remodeling by activation of Gp130-dependent signaling in mice","volume":"47","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.09.010_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2017.05.011","article-title":"Knockout of immunoproteasome subunit beta2i ameliorates cardiac fibrosis and inflammation in DOCA\/salt hypertensive mice","volume":"490","author":"Yan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjmcc.2019.09.010_bb0035","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2741\/4027","article-title":"Immune and non-immune functions of the immunoproteasome","volume":"17","author":"Angeles","year":"2012","journal-title":"Front. Biosci."},{"key":"10.1016\/j.yjmcc.2019.09.010_bb0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yjmcc.2013.10.008","article-title":"Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond","volume":"71","author":"Cui","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.09.010_bb0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.yjmcc.2011.10.023","article-title":"Back to your heart: ubiquitin proteasome system-regulated signal transduction","volume":"52","author":"Portbury","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.09.010_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yjmcc.2014.12.007","article-title":"Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP","volume":"79","author":"Li","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2019.09.010_bb0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.redox.2018.10.021","article-title":"Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload","volume":"20","author":"Chen","year":"2018","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.09.010_bb0060","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.117.10390","article-title":"Novel role for the immunoproteasome subunit PSMB10 in angiotensin II-induced atrial fibrillation in mice","volume":"71","author":"Li","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2019.09.010_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.redox.2018.02.022","article-title":"The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice","volume":"16","author":"Wang","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.09.010_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/HYPERTENSIONAHA.118.11813","article-title":"Immunoproteasome subunit beta5i promotes Ang II (angiotensin II)-induced atrial fibrillation by targeting ATRAP (Ang II type I receptor-associated protein) degradation in mice","volume":"73","author":"Li","year":"2019","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.yjmcc.2019.09.010_bb0075","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1800197","article-title":"Ablation and inhibition of the immunoproteasome catalytic subunit LMP7 attenuate experimental abdominal aortic aneurysm formation in mice","volume":"202","author":"Li","year":"2019","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.yjmcc.2019.09.010_bb0080","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1161\/CIRCULATIONAHA.115.020754","article-title":"Genetic and pharmacologic inhibition of the chemokine receptor CXCR2 prevents experimental hypertension and vascular dysfunction","volume":"134","author":"Wang","year":"2016","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.yjmcc.2019.09.010_bb0085","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"issue":"13","key":"10.1016\/j.yjmcc.2019.09.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93187","article-title":"Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction","volume":"2","author":"Shimizu","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.yjmcc.2019.09.010_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/cvr\/cvt258","article-title":"Inhibition of toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation","volume":"101","author":"Wang","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.09.010_bb0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/cvr\/cvr087","article-title":"Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology","volume":"91","author":"Nishijima","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"40","key":"10.1016\/j.yjmcc.2019.09.010_bb0105","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1038\/sj.onc.1206718","article-title":"Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway","volume":"22","author":"Zhang","year":"2003","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.yjmcc.2019.09.010_bb0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbadis.2014.09.002","article-title":"Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagy","volume":"1852","author":"Roe","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2019.09.010_bb0115","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.biopha.2018.04.141","article-title":"PTEN signaling inhibitor VO-OHpic improves cardiac myocyte survival by mediating apoptosis resistance in vitro","volume":"103","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.yjmcc.2019.09.010_bb0120","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.09.010_bb0125","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1096\/fj.201601147R","article-title":"PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production","volume":"31","author":"Liu","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.yjmcc.2019.09.010_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2017.08.005","article-title":"ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response","volume":"311","author":"Liu","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.09.010_bb0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cei.13132","article-title":"PR-957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke","volume":"193","author":"Guo","year":"2018","journal-title":"Clin. Exp. Immunol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282819301920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282819301920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:30:16Z","timestamp":1780421416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282819301920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"alternative-id":["S0022282819301920"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.09.010","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic ablation and pharmacological inhibition of immunosubunit \u03b25i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}